Advertisement

18 Results

for author "Thomas Bumm"

Type a term to search within all articles in this journal: e.g., stem cell
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-01-23
e.g., 2017-01-23
Format Results
  • Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
    Friederike Braig, Anna Brandt, Mariele Goebeler, Hans-Peter Tony, Anna-Katharina Kurze, Peter Nollau, Thomas Bumm, Sebastian Böttcher, Ralf C. Bargou, Mascha Binder
    ...Katharina Kurze Binder, M Peter, Nollau P Nollau T Bumm F Braig Brandt Anna Ralf Bargou Bottcher Böttcher, Sebastian Brandt, A Braig, F Thomas Nollau, P Goebeler Bargou Ralf C. Böttcher Bumm, T Mariele Brandt, Anna Tony Anna-Katharina S Böttcher R.C. Bargou Anna, Brandt Mariele Goebeler Friederike Braig ~~~
  • Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner
    Shigeo Fuji, Julia Fischer, Markus Kapp, Thomas G Bumm, Hermann Einsele, Stefan Stevanovic, Hans-Georg Rammensee, Thomas Hunig, Götz Ulrich Grigoleit
    ...Wilms Tumor Protein-1-Derived 9-Mer Peptide Induces CD4 T-Cell Responses in an HLA-DR Restricted Manner [] Grigoleit, G Grigoleit Fuji Shigeo Fischer Julia Ulrich Gotz Rammensee Stevanovic Stefan T Bumm Hermann, Einsele Stevanovic, S Markus, Kapp Markus Hunig, Thomas Bumm, T.G Grigoleit, Götz ~~~
  • BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
    Daniel W. Sherbenou, Oliver Hantschel, Ines Kaupe, Stephanie Willis, Thomas Bumm, Lalita P. Turaga, Thoralf Lange, Kim-Hien Dao, Richard D. Press, Brian J. Druker, Giulio Superti-Furga, Michael W. Deininger
    ...BJ Druker DW Sherbenou R.D. Press Brian Druker Druker DanielW Sherbenou Ines O Hantschel Press Sherbenou Turaga Lalita P. Stephanie Brian J, Druker T Bumm L Turaga RichardD Press D.W. Sherbenou Turaga, L.P Brian Daniel Sherbenou Thomas Press, R Michael W Deininger R Press Thoralf Press Richard D. MW ~~~
  • Jak2 V617F Induced TNF Resistance as a Mechanism of Clonal Expansion In Myeloproliferative Neoplasm
    Angela G. Fleischman, Karl J. Aichberger, Curtis L Petersen, Shirin Doratotaj, Thomas G Bumm, Heike L. Pahl, Brian J Druker, Michael W Deininger
    ...Druker AngelaG Fleischman Brian Druker AG Fleischman Angela G Fleischman Druker Petersen, CL T Bumm Brian J, Druker Doratotaj, Shirin Bumm, T.G Heike Pahl Brian Karl J Aichberger Thomas HL Pahl Doratotaj, S Michael W Deininger MW Deininger Bumm, TG S Doratotaj Bumm, Thomas G Doratotaj KJ Aichberger K ~~~
  • CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
    Jeffrey W. Tyner, Thomas G. Bumm, Jutta Deininger, Lisa Wood, Karl J. Aichberger, Marc M. Loriaux, Brian J. Druker, Christopher J. Burns, Emmanuelle Fantino, Michael W. Deininger
    ...Aichberger, KJ KarlJ Aichberger Loriaux, MM Druker, B.J MichaelW Deininger BJ Druker Deininger Jutta Brian Druker Druker Wood, Lisa Jeffrey Marc M Loriaux Fantino, E Wood Lisa T Bumm Brian J, Druker Bumm, T.G Christopher J Christopher J, Burns Tyner Jeffrey W. Brian Thomas Karl J Aichberger Tyner Jeffrey W E ~~~
  • TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
    Angela G. Fleischman, Karl J. Aichberger, Samuel B. Luty, Thomas G. Bumm, Curtis L. Petersen, Shirin Doratotaj, Kavin B. Vasudevan, Dorian H. LaTocha, Fei Yang, Richard D. Press, Marc M. Loriaux, Heike L. Pahl, Richard T. Silver, Anupriya Agarwal, Thomas O'Hare, Brian J. Druker, Grover C. Bagby, Michael W. Deininger
    ...T Bumm Doratotaj, Shirin Bumm, T.G Thomas Karl J Aichberger Press, R LaTocha Agarwal R Press MW Deininger Press, Richard D Richard T Anupriya, Agarwal Bumm, TG S Doratotaj Kavin Vasudevan Bumm, Thomas G Doratotaj KJ Aichberger TG Bumm K.J. Aichberger Heike L Thomas G Pahl, H Press, R.D LaTocha, D ~~~
  • Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD
    Thomas G.P. Bumm, Jeffrey W Tyner, Jutta Deininger, Marc Loriaux, Jonathan VanDyke, Brian J. Druker, Christopher J Burns, Emmanuelle Fantino3, Michael W.N. Deininger
    ...Burns Tyner, JW Bumm WN Deininger Michael W.N. Druker, B.J E Fantino3 ThomasGP Bumm GP BJ Druker Deininger Jutta Thomas GP Bumm Brian Druker Druker Fantino3 Jeffrey Deininger, Michael WN T Bumm Brian J, Druker Bumm, T.G Christopher J Christopher J, Burns Brian Thomas VanDyke, Jonathan Tyner Jeffrey W ~~~
  • Tumor Necrosis Factor-Alpha (TNF) Expression Is Elevated in Myelo-Proliferative Neoplasms (MPN) and Modulated by Inhibition of JAK2 V617F.
    Karl J. Aichberger, Angela G. Fleischman, Shirin Doratotaj, Thomas G.P. Bumm, Richard T. Silver, Thomas G. Deloughery, Heike L. Pahl, Brian J. Druker, Christopher J. Burns, Michael Deininger
    ...Druker AG Fleischman Druker Angela G Fleischman Silver Richard T. R.T. Silver Deloughery, TG Brian J, Druker T Bumm Doratotaj, Shirin Deloughery, T Bumm, T.G Christopher J Christopher J, Burns Heike Pahl Brian Karl J Aichberger Thomas HL Pahl Doratotaj, S Richard T, Silver Thomas G, Deloughery ~~~
  • Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib.
    Ian J. Griswold, Thomas Bumm, Thomas O’Hare, Erika M. Moseson, Brian J. Druker, Michael W. Deininger
    ...Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib. [] Deininger Moseson, Erika M M.W. Deininger O’Hare, T EM Moseson Brian J, Druker T Bumm E Moseson Moseson Erika M. Moseson, E.M Erika M Moseson Brian BrianJ Druker Brian J Druker Thomas Moseson, EM ~~~
  • Chromosomal Abnormalities in the Early Stem Cell Population of CML Patients in Complete Cytogenetic Remission.
    Thomas G.P. Bumm, Amy Hanlon Newell, Jay Oost, Jonathan VanDyke, Susan B. Olson, Brian J. Druker, Michael W.N. Deininger
    ...Chromosomal Abnormalities in the Early Stem Cell Population of CML Patients in Complete Cytogenetic Remission. [] Deininger Newell, AH Deininger, Michael WN M.W. Deininger Brian J, Druker T Bumm Bumm, T.G AH Newell Jonathan, VanDyke Brian Bumm Thomas G.P. BrianJ Druker Brian J Druker Thomas Van ~~~

Pages